Mosquitoes, Beware! Penta5 USA Retains TransMedia To Create Media Buzz About Its New Non-Toxic, Independently-Tested And Validated Product That Makes Mosquitoes Lose Their Appetite For Human Blood.
SARASOTA, Fla., July 25, 2016 /PRNewswire/ -- Penta5 USA has retained TransMedia Group to inform consumers how its new patented mosquito repellent, MosquitoPaQ ANYTIME™ no-bite lotion, has been shown by independent laboratories to block key receptors used by mosquitoes to locate people as prey.
TransMedia will publicize all of the company's products lines, but with the Zika virus surging, the international PR firm will focus on the non-toxic, chemical free, patented mosquito lotion that can be safely used around children, pets and wildlife. A single application can shield a user from mosquitoes and the diseases they carry for over six, and up to 12 hours!
"Here is one versatile company, soon to be going public, brimming with successful science-based, natural, eco-friendly wellness products--many effectively attacking serious health concerns. We're going to offer Penta5's ANYTIME™ no-bite repellent lotion to the NBC Television crew who'll be covering the Olympics," said Tom Madden, CEO of TransMedia Group and a former NBC vice president.
"Because Penta5's sales are global, we sought an international PR firm to represent us. One with a multilingual staff and world-wide presence and also operates a lot like we do, resourcefully,creatively and effectively," said Penta5 USA CEO R. Charles Murray.
"MosquitoPaQ™ ANYTIME™ no-bite products standout in that they do not kill the female mosquito and are all natural, environmental friendly, contain no DEET or other chemicals and are non-toxic child and pet safe. A real first in this battle to eradicate mosquito diseases." said Madden.
Media contact: Tim Allen 561-750-9800 x2220; [email protected].
Penta5 USA contact: Sandra Murray 941-359-6678; [email protected]
SOURCE TransMedia Group
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article